PapersPMID:34684621
The Effect of Daily Methylsulfonylmethane (MSM) Consumption on High-Density Lipoprotein Cholesterol in Healthy Overweight and Obese Adults: A Randomized Controlled Trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- no difference found
- 1
- Study, every finding
- RCT · 4 months
- Dose studied, every finding
- 3 g/day MSM (OptiMSM) vs placebo capsules of white rice flour
What moved
How to read these marks →“CRP was significantly lower in MSM compared to placebo at week 16 (p = 0.04).”
- Interests
- Industry funded
- Population
- Healthy overweight or obese adults (BMI 25 or above), 22 completers; week 16 timepoint
What did not
“The total antioxidant capacity of the serum was not different between the MSM and placebo group (Table 3).”
- Interests
- Industry funded
- Population
- Healthy overweight or obese adults (BMI 25 or above), 22 completers
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- healthy overweight and obese adults, BMI 25 kg/m2 or above
- Participants
- 22
- Comparator
- placebo
- Duration
- 112 days
- Endpoints measured
- 26